Fig. 6.
Thrombin stimulation of Egr-1 mRNA in primary endothelial cells is mediated by an ERK1/2 MAPK–dependent pathway.
HPAECs were starved overnight in EBM-2 medium containing 0.5% FBS and then treated with or without 1.5 U/mL thrombin for 1 hour. Alternatively, the serum-starved cells were preincubated with 20 μM PD98059 (PD), 3 μM SB203580 (SB), 5 μM BIM, 10 μM LY294002 (LY), or dimethyl sulfoxide (DMSO) (1 μL as solvent control) for 10 minutes and then incubated for 1 hour with medium containing no thrombin or 1.5 U/mL thrombin. RNase protection assays were carried out with α-[32P] UTP-labeled Egr-1 and β-actin probes as described in “Materials and methods.” Densitometry was used to calculate the ratio of Egr-1 and β-actin signals. The results are expressed as fold induction relative to control untreated cells. The data represent the means and standard deviations from 3 independent experiments.